ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Middle Ear Implants Offer Potential: New breed of devices may stimulate compliance, experts say

by David H. Kirkwood • April 27, 2011

  • Tweet
  • Email
Print-Friendly Version
Middle Ear Implants Offer Potential

You Might Also Like

  • Bone-Anchored Hearing Aids Offer Viable Alternative to Standard Devices
  • Newly Formed Society for Middle Ear Disease Aims to Educate, Advocate
  • Management of an Unusual Middle Ear Foreign Body
  • Device Offers Effective Alternative to Middle Ear Surgery, Hearing Aids
Explore This Issue
May 2011
An image of the Esteem hearing implant. The sound processor is implanted behind the ear.

For decades, otolaryngologists have been frustrated by the refusal of some patients with hearing loss to use hearing aids. Statistics on noncompliance vary, but there is general agreement that only about 20 percent to 25 percent of Americans with treatable hearing loss use hearing aids (Hear Rev. 2009;16(11):12-31). The problem seems to be more acute for people with mild hearing loss: A consumer survey conducted by the nonprofit Better Hearing Institute in 2009 found that fewer than 10 percent of people with mild hearing loss use amplification and that even among people with moderate-to-severe hearing loss, only four in 10 use amplification (Hear Rev. 2010;17(6):12,14-16).

Non-users offer many reasons for going unaided, including the high cost of hearing aids, the inconvenience of wearing them, the fear of seeming old, and negative reports from friends and family who have tried them. But an emerging category of hearing devices, middle ear implants (MEIs), may offer a solution to the noncompliance problem, experts say.

“If you have a patient whose hearing is not bad enough for a cochlear implant but who is really dissatisfied with hearing aids, that is a niche for implantable devices,” said Moisés A. Arriaga, MD, MBA, FACS, who has participated in clinical trials of several models of MEIs. Dr. Arriaga is professor of otolaryngology and neurosurgery at Louisiana State University and director of Our Lady of the Lake Hearing and Balance Center in Baton Rouge, La.

Options

Patients can choose between partially implantable and totally implantable systems. In the former, the receiver is implanted on the ossicular chain, while the microphone, battery and, in some cases, the processor are external. In the latter, every component is surgically implanted except for a remote control that lets the wearer adjust the volume and turn the device on and off.

Currently, three companies have U.S. Food and Drug Administration (FDA)-approved middle ear implants: MED-EL, an Austria-based company that in 2003 purchased the Vibrant Soundbridge technology from Symphonix; Ototronix, which makes the Maxum System, a device based on SOUNDTEC Inc.’s FDA-approved Direct System; and Envoy Medical Corp., of Minneapolis, which received FDA clearance for its totally implantable Esteem system in March 2010. A fourth company, Otologics, has both semi-implantable and totally implantable systems on the market in Europe, but neither has been approved in the U.S.

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Everyday Ethics, Otology/Neurotology, Special Reports, Tech Talk Tagged With: insurance, Otology, patient complianceIssue: May 2011

You Might Also Like:

  • Bone-Anchored Hearing Aids Offer Viable Alternative to Standard Devices
  • Newly Formed Society for Middle Ear Disease Aims to Educate, Advocate
  • Management of an Unusual Middle Ear Foreign Body
  • Device Offers Effective Alternative to Middle Ear Surgery, Hearing Aids

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Otolaryngologists Have a Major Role to Play in Treating COVID-19 Long-Haulers
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.